Summary
Cisplatin (3 mg/kg) was infused through the hepatic artery in nine mongrel dogs. Four of these dogs underwent simultaneous extracorporeal hemofiltration (ECH) of the hepatic venous effluent using a high-flow, dual-lumen catheter placed in the vena cava at the level of the hepatic veins. Platinum levels were measured in the plasma, urine, and ultrafiltrate and in kidney and liver tissue. ECH significantly reduced systemic drug exposure as measured by the AUC for free and total platinum, by urinary excretion, and by 24-h kidney levels. Regional liver levels were minimally affected. Recovery of platinum in the ultrafiltrate was 40% ± 14%. ECH resulted in efficient extraction of platinum and reduced systemic drug exposure with relative preservation of regional hepatic drug exposure.
Similar content being viewed by others
References
Aigner KR, Müller H, Walther H, Link KH (1988) Drug filtration in high-dose regional chemotherapy. In: Aigner KR, Patt YZ, Link KH, Kreidler J (eds) Contributions to oncology. Karger, Basel, p 261
Aronsen KF, Teder H, Lindberg B (1986) Indications and therapeutic possibilities using degradable microspheres in liver malignancies. Recent Results Cancer Res: 282
Berger MR, Henne TH, Aguilar JLA, Bartkowski R, Dörsam J, Geelhaar GH, Schlag P, Herfarth C, Schmähl D (1986) Experiments on the toxicity of locoregional liver chemotherapy with 5-fluoro-2′-deoxyuridine and 5-fluorouracil in an animal model. Recent Results Cancer Res 100: 148
Boddie AW, Booker L, Mullins JD, Buckley CJ, McBride CM (1979) Hepatic hyperthermia by total isolation and regional perfusion in vivo. J Surg Res 26: 447
Chen GH, Gross JF (1980) Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64: 31
Collins JM (1984) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2: 498
Collins JM (1986) Pharmacologic rationale for hepatic arterial therapy. Recent Results Cancer Res 100: 140
Cumberlin R, De Moss E, Lassus M, Friedman M (1985) Isolation perfusion for malignant melanoma of the extremity: a review. J Clin Oncol 3: 1022
Dedrick RL (1988) Arterial drug infusion: pharmacokinetic problems and pitfalls. J Natl Cancer Inst 80: 84
Dedrick RL, Oldfield EH, Collins JM (1984) Arterial drug infusion with extracorporeal removal: I. Theoretic basis with particular reference to the brain. Cancer Treat Rep 68: 373
Eckman WW, Patlak CS, Fenstermacher JD (1974) A critical evaluation of the principles governing the advantages of intra-arterial infusions. J Pharmacokinet Biopharm 2: 257
Freeman AI, Mayhew E (1986) Targeted drug delivery. Cancer 58: 573
Frei E, Canellos GP (1980) Dose: a critical factor in cancer chemotherapy. Am J Med 69: 585
Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York
Hohn D, Melnick J, Stagg R, Altman D, Friedman M, Ignoffo R, Ferrell L, Lewis B (1985) Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol 3: 98
Hohn DC, Shea WJ, Gemlo BT, Lewis BJ, Stagg RJ, Ignoffo RJ, Rayner AA (1988) Complications and toxicities of hepatic arterial chemotherapy. In: Aigner KR, Patt YZ, Link KH, Kreidler J (eds) Contributions to oncology. Karger, Basel, p 169
Howell SB (1988) Pharmacokinetic principles of regional chemotherapy. In: Aigner KR, Patt YZ, Link KH, Kreidler J (eds) Contributions to oncology. Karger, Basel, p 1
Kajanti M, Rissanen P, Virkkunen P, Franssila K, Mantyla M (1986) Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma. Cancer 58: 2386
Krementz ET (1986) Regional perfusion: current sophistication, what next? Cancer 57: 416
Laughlin EH (1986) Common duct stricture associated with hepatic artery infusion of FUDR. J Surg Oncol 31: 56
Oldfield EH, Dedrick RL, Yeager RL, Clark WC, DeVroom HL, Chatterji DC, Doppman JL (1985) Reduced systemic drug exposure by combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage. J Neurosurg 63: 726
Oldfield EH, Clark WC, Dedrick RL, Egorin MJ, Austin HA, DeVroom HD, Joyce KM, Doppman JL (1987) Reduced systemic drug exposure by combining intraarterialcis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage. Cancer Res 47: 1962
Sakurai M, Okamura J, Kuroda C (1984) Transcatheter chemoembolization effective for treating hepatocellular carcinoma. Cancer 54: 387
Sasaki Y, Imaoka S, Hasegawa Y, Nakano S, Ishikawa O, Ohigashi H, Taniguchi K, Koyama H, Iwanaga T, Terasawa T (1985) Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer 55: 311
Siddik ZH, Boxall FE, Harrap KR (1987) Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hyamine hydroxide. Anal Biochem 163: 21
Siddik ZH, Newell DR, Boxall FE, Harrap KR (1987) The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Biochem Pharmacol 36: 1925
Skipper HE (1979) Historic milestones in cancer biology: a few that are important in cancer treatment (revisited). Semin Oncol 6: 506
Starkhammar H, Hakansson L, Morales O, Svedberg J (1987) Effect of microspheres in intra-arterial chemotherapy. A study of arteriovenous shunting and passage of a labelled marker. Med Oncol Tumor Pharmacother 4: 87
Venook A, Chase J, Stagg R, Lewis B, Ring E, Maroney T, Hohn D (1989) A phase I–II trial of angiostat/mitomycin C hepatic chemoembolization for colorectal cancer metastatic to the liver. Proc Am Soc Clin Oncol 8: 120
Author information
Authors and Affiliations
Additional information
These studies were supported by the Ben Marcus Bequest and The University of Texas M. D. Anderson Cancer Center New Program Development Fund
Rights and permissions
About this article
Cite this article
Graham, R.A., Siddik, Z.H. & Hohn, D.C. Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy. Cancer Chemother Pharmacol 26, 210–214 (1990). https://doi.org/10.1007/BF02897201
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02897201